HEALTH AND HAPPINESS (H&H) INTERNATIONAL HOLDINGS LIMITED

Health and Happiness (H&H) International Holdings Limited

1112

KYG4387E1070

Food Processing

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
10.9 ^HKD	-0.55%		+4.01%	-9.92%

May. 17	Health and Happiness' Revenue Down 9% in Q1	MT
May. 10	Health and Happiness (H&H) International Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023	CI

Health and Happiness (H&H) International Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022

May 12, 2023 at 05:17 am EDT

Health and Happiness (H&H) International Holdings Limited at the AGM, the shareholders approved to declare a final dividend equivalent to HKD 0.38 per ordinary share for the year ended 31 December 2022 to the shareholders of the Company which shall be distributed from the retained profits of the company.

Latest news about Health and Happiness (H&H) International Holdings Limited

Health and Happiness' Revenue Down 9% in Q1	May. 17	MT
Health and Happiness (H&H) International Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023	May. 10	CI
Health and Happiness (H&H) International Holdings Limited Proposes Issue and Pricing of USD 120,200,000, 13.5% Senior Notes due 2026	Apr. 08	CI
Jefferies Adjusts Health and Happiness International’s Price Target to HK$13 From HK$14, Keeps at Buy	Mar. 28	MT
H&H’s Profit Down 5% in 2023	Mar. 26	MT
Health and Happiness (H&H) International Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 10, 2024	Mar. 26	CI
Health and Happiness (H&H) International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Health And Happiness (H&H) International to Issue 500 Million Yuan of Bonds	Mar. 20	MT
Health and Happiness (H&H) International Holdings Limited Announces Pricing of RMB 500,000,000 7.5% Guaranteed Bonds Due 2027	Mar. 20	CI
H&H International Warns of Profit Decline	Mar. 05	MT
Jefferies Adjusts Health and Happiness International’s Price Target to HK$14 From HK$13.10, Keeps at Buy	Jan. 16	MT
Health and Happiness (H&H) International Holdings Limited Appoints Mrs. Mingshu Zhao Wiggins as Non-Executive Director, Effective from 1 January, 2024	Dec. 29	CI
H&H International CEO Steps Down, Sets Up Rotational CEO Structure	Nov. 19	MT
Health and Happiness (H&H) International Holdings Limited Announces Cessation of Camillo Pane as Chief Executive Officer	Nov. 19	CI
Jefferies Adjusts Health and Happiness International’s Price Target to HK$13.10 From HK$13, Keeps at Buy	Nov. 02	MT
H&H International Partially Buys Back Bonds Due in 2024	Nov. 01	MT
H&H International Holdings' Q3 Revenue Jumps 2%	Nov. 01	MT
Health and Happiness (H&H) International Holdings Limited Reports Unaudited Consolidated Revenue Results for the Three Months and Nine Months Ended 30 September 2023	Nov. 01	CI
H&H International Holdings Repurchases $4.1 Million in 2026 Bonds	23-09-05	MT
Jefferies Adjusts Health and Happiness International’s Price Target to HK$13 From HK$13.40, Keeps at Buy	23-08-24	MT
Transcript : Health and Happiness (H&H) International Holdings Limited, H1 2023 Earnings Call, Aug 23, 2023	23-08-22
Health and Happiness (H&H) International Holdings Limited Declares Interim Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 13 October 2022	23-08-22	CI
Health and Happiness (H&H) International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
H&H International Holdings' First-Half Revenue Grows in Double Digits; Shares Rise 5%	23-07-18	MT
Health & Happiness (H&H) Announces Senior Notes Offering	23-06-28	MT

Chart Health and Happiness (H&H) International Holdings Limited

Duration

Period

Chart Health and Happiness (H&H) International Holdings Limited

More charts

Company Profile

Health and Happiness (H&H) International Holdings Limited, formerly Biostime International Holdings Ltd., is an investment holding company principally engaged in the manufacture and sale of premium pediatric nutritional. The Company operates through five business segments. The Infant Formulas segment is engaged in the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment is engaged in the production of vitamins, health supplements, skin care and sports nutrition products for adults. The Probiotic Supplements segment is engaged in the production of probiotic supplements. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods, as well as microencapsulated milk calcium chewable tablets. The Baby Care Products segment is engaged in the production of baby care products.

Sector

Food Processing

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company